FDA
approval
· 2026-03-12
FDA Approved: POMALIDOMIDE — Supplemental Application (Teva Pharmaceuticals, Inc.)
Summary
The FDA approved Teva's supplemental application for pomalidomide, authorizing the generic pomalidomide to be marketed. This represents a supplemental approval …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for POMALIDOMIDE (POMALIDOMIDE)